Silexion Therapeutics prices $6.0M public offering of shares and warrants

Silexion Therapeutics Corp

Raised $6.0M gross ($5.2M net) from sale of 1.5M share equivalents and warrants at $4.00/unit.
Offering includes Series A (5-year) and Series B (12-month) warrants, each exercisable at $4.00/share.
Placement agent H.C. Wainwright receives 7% cash fee plus 105,000 placement agent warrants at $5.00.
Net proceeds to fund pre-clinical studies and general corporate purposes.
Offering closed on Sept 12, 2025; securities registered under Form S-1 effective Sept 11.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.